OpenVSafe by OpenVAERS
Search V-safe

DCG-78105-36349

3 vaccinations 8 coded responses 32 check-ins 8 free-text entries 0 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
550 / MN
Registered
2021-01-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-11
    Registered in v-safe
  2. 2021-01-11
    Dose 1 — Moderna
  3. 2021-01-11
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-18
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-25
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-01
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-02-04
    Dose 2 — Moderna
  14. 2021-02-04
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  17. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  19. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-11
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-18
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-25
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-11
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-03-18
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-05-06
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-05
    Survey response — 6 months, dose 2
    MedDRA: Pneumonia, Renal cell carcinoma — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Diagnosed with Mycobacteria lung infection and renal cell carcinoma
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2021-10-20
    Dose 3 — Moderna
  29. 2021-10-24
    Survey response — days 1–6 daily, dose 3
    MedDRA: Metastatic renal cell carcinoma, Oropharyngeal pain, Stomatitis — Feeling: Good · Be unable to work or attend school
    Free text: I have sore throat and mouth sores but believe them to be side effects from cancer med I am taking for mRCC diagnosed in August 2021
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-25
    Survey response — days 1–6 daily, dose 3
    MedDRA: Renal cell carcinoma — Feeling: Good · Be unable to work or attend school
    Free text: Diagnosed in August with renal cell carcinoma
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-26
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oropharyngeal pain, Renal cell carcinoma — Feeling: Good
    Free text: Sore throat but thinking it is side effect of Lenvima med being taken for recently diagnosed Renal Cell Carcinoma
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-10-29
    Survey response — day 7, dose 3
    MedDRA: Pre-existing disease — Feeling: Good · Be unable to work or attend school
    Free text: Received Keytruda infusion today for renal cancer treatment
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-11-03
    Survey response — day 14, dose 3
    MedDRA: Blood thyroid stimulating hormone increased, Pre-existing disease — Feeling: Good · Be unable to work or attend school
    Free text: Elevated TSH, most probably due to Lenvima med to RCC treatment
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-11-12
    Survey response — day 21, dose 3
    MedDRA: Headache — Feeling: Fair
    Free text: Headache for last 8 days
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-11-17
    Survey response — day 28, dose 3
    MedDRA: Headache, Myalgia, Pain — Feeling: Fair · Be unable to work or attend school
    Free text: Muscle and body aches. Ongoing headache for two weeks Most likely side effects of cancer treatment meds
    MedDRA releases: 2024-11 · check-in free text available
  36. 2021-11-24
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-11Moderna
22021-02-04Moderna
32021-10-20Moderna No

Free text

Release 9 — 6 months, dose 2

2021-08-05

Symptoms: Diagnosed with Mycobacteria lung infection and renal cell carcinoma

Release 10 — days 1–6 daily, dose 3

2021-10-24

Systemic reaction (other): I have sore throat and mouth sores but believe them to be side effects from cancer med I am taking for mRCC diagnosed in August 2021

2021-10-25

Systemic reaction (other): Diagnosed in August with renal cell carcinoma

2021-10-26

Systemic reaction (other): Sore throat but thinking it is side effect of Lenvima med being taken for recently diagnosed Renal Cell Carcinoma

Release 10 — day 7, dose 3

2021-10-29

Systemic reaction (other): Received Keytruda infusion today for renal cancer treatment

Release 10 — day 14, dose 3

2021-11-03

Symptoms: Elevated TSH, most probably due to Lenvima med to RCC treatment

Release 10 — day 21, dose 3

2021-11-12

Symptoms: Headache for last 8 days

Release 10 — day 28, dose 3

2021-11-17

Symptoms: Muscle and body aches. Ongoing headache for two weeks Most likely side effects of cancer treatment meds

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBlood thyroid stimulating hormone increased · · ✓
SDHeadache · · ✓
SDMyalgia · · ✓
SDPain · · ✓
SDPneumonia ✓ · ✓
SDPre-existing disease · · ✓
SDRenal cell carcinoma ✓ · ✓
SROMetastatic renal cell carcinoma · · ✓
SROOropharyngeal pain · · ✓
SROPre-existing disease · · ✓
SRORenal cell carcinoma · · ✓
SROStomatitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release